Drug Prevents Multiple Sclerosis Relapses in Phase III Trial
The first effective MS treatments became available two decades ago, but the new study is the latest to demonstrate the much greater effectiveness of a new type of treatment
Autoimmune Diseases
Gene Variations at Birth Reveal Origins of Inflammation and Immune Disease
New research has identified several genes that appear to drive disease risk at birth, and which could be targeted for therapeutic intervention to stop these diseases
Fecal Transplants Show Promise as Treatment for NAFLD
Trial results could have implications for the treatment of numerous conditions including metabolic syndrome and autoimmune diseases
Autoimmunity May Be Rising in the United States
In a recent study, NIH researchers and their collaborators found that the most common biomarker of autoimmunity is significantly increasing in the US
New WHO Autoantibody Reference Reagent Will Benefit SLE Patients
Systemic lupus erythematosus (SLE) is a systemic rheumatic disease mainly affecting women in childbearing age, that is associated with inflammatory symptoms from multiple organs
Drug Resistance Signature Discovered in Crohn's Disease
Finding may create opportunity to test patients to avoid ineffective drugs
Bioelectronic Medicine Treatment Effective for Lupus
Lupus causes the immune system to lose the ability to differentiate between foreign agents and healthy tissue
Link Between Gut Flora and Multiple Sclerosis Discovered
Results show that gut microbiota could play a far greater role in the pathogenesis of MS than previously assumed